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S U M M A R Y
Background: Zoonoses are human infectious diseases caused by pathogens that primarily infect animals.
Mediterranean Spotted Fever (MSF) represents one such example, affecting the Mediterranean region, in
which household animals can be immune-carriers of infected ticks.
Materials and methods: We retrospectively analysed the incidence and the clinical and laboratory
features of MSF caused by R.Conorii in children admitted to the Paediatric Operative Unit from 1987 to
2010, for persistent fever and generalised macular-popular erythematous lesions.
Clinical, immunological and serological parameters of 55 cases of Rickettsia infections observed in
children between 2 and 11 years of age were collected.
Results: We found an increasing incidence of MSF in childhood from 1987 to 2010. Diagnosis of MSF at
the moment of hospital admission was done in 16 patients (29.09%). The presence of the typical Tache
noire was observed in 16 cases out of 55 patients (29.09% of cases).
We noticed a different representation of R. conorii antigens in serological testing over the time period
of the study, corresponding to overall higher incidence rates for infection in the latter years. We also
observed a higher incidence of infection in those years in which all four antigens were found positive at
serum testing with respect to those years in which only two of the four antigens were observed (1987-
1990: 0-16%; 2007-2010: 0.46%; P<0.005).
Conclusions: These changes in R. conorii antigenicity may be the cause of higher pathogenicity in this
parasite, perhaps linked to increased immigration along with consequent changes in the epidemiology of
infectious diseases in host countries.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Zoonoses are human infectious diseases caused by pathogens
that primarily infect animals, with examples including Brucellosis,
Tetanus, Toxoplasmosis, Leptospirosis, Rickettsiosis, Echinococcosis,
Teniasis).1 It is important to conduct epidemiologic studies of these
infectious diseases, recording up-to-date data to inform prevention
measures adopted in every region, including vaccine- and* Corresponding author. AOU Policlinico-OVE, Via Plebiscito n. 628, 95100
Catania. Tel.: +39 0957435254.
E-mail address: giovitaliti@yahoo.it (G. Vitaliti).
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1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).serum-prophylaxis as well as environmental reclamation, since
their incidence is still elevated in rural areas such as Sicily and
Sardinia.1–3
Mediterranean Fevers, usually caused by Rickettsia microorgan-
isms, represent a diagnostic challenge, often with delayed diagnosis
with respect to the onset of the disease itself. Mediterranean Fever is
an interesting topic of research in areas with a high rural density,
such as the Mediterranean areas, in which household animals can be
immune carriers of infected ticks.1,2
Data from the Italian National Statistic Institute (ISTAT) show
that of 1489 cases of Mediterranean fever, 569 (33%) have been
diagnosed in Sicily and 333 (22%) in Sardinia.3 Nevertheless,
these data are a likely underestimate because most cases are notciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
G. Vitaliti et al. / International Journal of Infectious Diseases 31 (2015) 35–4036reported to the relevant authorities and have been treated in
regional paediatric hospitals, with a relatively higher risk of severe
complications.4
Rickettsial infections include a range of microorganisms of the
Rickettsia family. These are considered obligate intracellular
parasites able to multiply in one or more species of arthropods
and can affect both animals and humans. They are divided into the
following subgroups.5,6:
- Rickettsia of the typhus fever group: murine typhus (R. mooseri)
and epidemic typhus (R. prowazekii), respectively transmitted by
ﬂeas and lice; they affect a widespread geographical distribution
with infection linked to the presence of rats for R. mooseri, and
lack of social hygiene for R. prowazekii.
- Rickettsia causing spotted fevers: Rocky Mountain spotted fever
(RMSF) (R. rickettsii) and Mediterranean spotted fever (MSF) (R.
conori) transmitted by ticks; R. rickettsii is prevalent in United
States of America, while R. conori is widespread in the
Mediterranean area, Africa and India.
Rickettsioses are considered benign infectious diseases, al-
though 10% of patients can develop severe complications. The
RMSF and the MSF usually cause endothelial damage, leading to
coagulation abnormalities from platelet deprivation (most com-
mon) to Disseminated intravascular coagulation (DIC).7 MSF is
endemic in the Mediterranean area, and recent cases of particular
seriousness have been reported with severe clinical presentation.7
The aim of our study was to retrospectively analyse the
incidence as well as clinical and laboratory parameters of
Rickettsioses cases causing MSF in children admitted to the
Paediatric Operative Unit of the Policlinico-Vittorio Emanuele
University Hospital, University of Catania, Italy, from 1987-2010.
2. Materials and methods
Our study is a retrospective analysis of the incidence of
Rickettsioses in childhood and the clinical, immunological and
serological parameters of infected patients, observed in children
between 2 and 11 years of age admitted to the Paediatric Operative
Unit of the Policlinico-Vittorio Emanuele University Hospital,
University of Catania, Italy, from 1987-2010, who initially
presented with persistent fever of unknown origin.
All included patients had been admitted to our Operative Unit
after 7 days of fever, not responding to common antibiotics, and
generalised macular-papular erythematous lesions.
We excluded all patients affected by known, previously
diagnosed, infectious diseases, chronic disease such as diabetes,
renal failure, congenital heart disease as well as genetic and
metabolic disorders or undergoing any immune-suppressant
therapy.
In order to calculate the incidence of the diseases during the
considered years, we divided the patients into 6 subgroups
according to chronological parameters:
- Group 1: children admitted from 1987 to 1990;
- Group 2: patients admitted from 1991 to 1994;
- Group 3: subjects admitted from 1995 to 1998;
- Group 4: children admitted from 1999 to 2002;
- Group 5: patients admitted from 2003 to 2006;
- Group 6: patients admitted from 2007 to 2010.
All patients underwent full routine, metabolic and infective
blood analyses, including the coagulation proﬁle, inﬂammatory
indexes, immunological proﬁle, and serologic parameters with
serum-diagnosis evaluation. The results of these analyses were
then consecutively recorded in our electronic database.Patients also underwent a cardiac, lung and abdominal
evaluation by ECG, echocardiography, chest X-ray, abdomen and
renal ultrasound scan, in order to exclude any organ dysfunction or
failure.
After the results of serological testing, all patients underwent
appropriate therapy to eliminate the infection and supportive
therapy for associated symptoms.
2.1. Statistical analysis
All routine analyses of numeric values from clinical evaluation
are expressed as absolute values in mean and standard deviation
(SD).
The percentage statistic values were obtained using the
frequency calculation test.
The comparison between percentages was performed by the
Chi-Squared Test
3. Results
Our study included 55 patients, 29 males and 26 females, with
mean age 5.6 years 3.12 standard deviation (SD).
The demographic parameters and routine blood analysis of the
included patients are shown in Table 1. The immunological and
serological blood parameters of the studied patients are shown in
Table 2. The clinical features and therapeutic follow-up of the
included patients are shown in Table 3.
We found an increasing incidence of MSF in childhood from
1987 to 2010. The incidence of MSF was as follows: 0.16% of
hospital admissions (HA) from 1987 to 1990; 0.31% of HA from
1991 to 1994; 0.26% of HA from 1995 to 1998; 0.28% of HA from
1999 to 2002; 0.36% of HA from 2003 to 2006; 0.46% of HA from
2007 to 2010.
In our observation, a conﬁrmed diagnosis of MSF at ﬁrst hospital
admission was achieved in 16 patients (29.09%). All patients (100%
of cases) were referred to our Hospital for persistent fever and skin
rash, variably associated with other non-speciﬁc symptoms
including headache, abdominal pain, joint pain, muscular pain,
fatigue, and less frequently vomiting, diarrhoea and lack of
appetite. In 2 patients (3.63%) we found the presence of bilateral
conjunctivitis.
In most cases the history was negative for tick bite; only 16% of
cases reported a tick puncture before the onset of symptoms,
whereas this was unobserved in 84% of cases.
The presence of the classic Tache noire was observed in 16 cases
out of 55 patients affected by MSF (29.09% of cases). This lesion was
observed in all cases on the site of the tick puncture if reported and
was not painful nor itchy.
Skin rash usually manifested 3-4 days after the onset of fever,
with a primarily typical distribution on hands, feet and limbs, and a
subsequent spread (after 24-36 hours) to the trunk, neck, face,
hands and feet. This evolution and its distribution were not
consistent in all patients as they could be altered by the use of
various antibiotics.
Lesions initially were maculo-papular with a light pink colour
and were irregularly deﬁned. Their centripetal distribution was
consistent with a measles rash, an important differential diagnosis.
All patients were admitted to the hospital for a variable period
of time, with a minimum of 3 days to a maximum of 14 days
(Table 3). Furthermore, fever and symptom duration showed a
variable time, lasting from a minimum of 2 days to a maximum of
10 days (Table 3).
All blood parameters and immunological parameters were
within normal range, with the exception of inﬂammatory markers
that in most cases were elevated (Table 1).
Table 1
demographic parameters and routine blood analyses levels, expressed as mean and standard deviation, of patients enrolled in our study, stratiﬁed by groups of years.
Distribution
of patients
by range
of years
Number
of cases
diagnosed
Presence
of Tache
noir
Hb
(mg/dl)
RBC
cells/mmc
WBC
cells/mmc
Leucocyte
formula
%
Platelet
count
cells/mmc
VES Tot.
Blood
Proteins
(g/dl)
Fractionate
Blood
Proteins
(g/dl)
C reactive
protein
(mg/dl)
Transaminases
(UI/l)
Renal
function
and
electrolytes
1987-1990 5
(2M and
3 F)
1%
(1 in
5 cases)
12.381.04 4.590.000  0.31 9.340
4000.42
Neutr. 46.425.52
Lymph. 5125.71
Monoc. N.R.
Eosinoph. N.R.
Basoph. N.R.
198.60073.93 41.7 13.62 6.620.16 Alb. 544.89
Alpha1 prot: 4.80.83
Alpha2 prot: 14.42.3
Beta protc¸ 12.23.34
Gamma prot: 16.23.63
22.31
13.38
ALT: 56.216.16
AST
44.820.89
N.R.
1991-1994 10
(5M and
5 F)
10%
(1 in
10 cases)
11.861.08 4.590.000  0.49 6.660
1000.06
Neutr. 41.918.65
Lymph. 46.118.44
Monoc. N.R.
Eosinoph. N.R.
Basoph. N.R.
208.80057.05 42.9 13.36 6.470.33 Alb. 58.33.91
Alpha1 prot: 4.21.61
Alpha2 prot: 11.82.89
Beta prot: 10.81.22
Gamma prot: 163.82
18.5511.55 ALT: 39.317.02
AST
40.810
N.R.
1995-1998 8
(5M and
3 F)
12.5%
(1 in
8 cases)
11.291.40 4.570.000  0.44 7.780
2000.30
Neutr. 50.513.92
Lymph. 41.2514.16
Monoc. N.R.
Eosinoph. N.R.
Basoph. N.R.
256.000109.94 58.25 23.03 6.780.76 Alb. 52.873.04
Alpha1 prot: 41.30
Alpha2 prot: 14.752.31
Beta prot: 12.621.3
Gamma prot: 15.372.44
39.1229.98 ALT: 39.1420.57
AST
42.4211.42
N.R.
1999-2002 7
(5M and
2 F)
14.28%
(1 in
7 cases)
12.401.06 4.317.000  0.28 7.928
4000.14
Neutr. 47.5718.23
Lymph. 51.7118.16
Monoc. N.R.
Eosinoph. N.R.
Basoph. N.R.
191.14230.98 38.55 10.98 7.642.60 Alb. 62.571.81
Alpha1 prot: 3.280.48
Alpha2 prot: 8.572.14
Beta prot: 9.140.89
Gamma prot: 16.853.57
10.123.89 ALT: 40.719.03
AST
41.1416.48
N.R.
2003-2006 11
(5M and
6 F)
36.36%
(4 in
11 cases)
13.403.04 4.550.000  0.27 8.706
4000.14
Neutr. 40.2315.14
Lymph. 54.9218.19
Monoc. N.R.
Eosinoph. N.R.
Basoph. N.R.
248.18123.40 52.86 16.87 6.320.66 Alb. 54.095.26
Alpha1 prot: 5.061.14
Alpha2 prot: 13.742.48
Beta prot: 11.761.33
Gamma prot: 13.364.72
57.5361.72 ALT: 39.5419.49
AST
46.3625.76
N.R.
2007-2010 14
(7M and
7 F)
57.14%
(8 in
14 cases)
12.961.54 4.257.000  0.512 7.848
3546.24
Neutr. 42.2219.51
Lymph. 55.4323.72
Monoc. N.R.
Eosinoph. N.R.
Basoph. N.R.
223.2482.78 45.23 12.14 6.640.45 Alb. 55.644.28
Alpha1 prot: 6.671.12
Alpha2 prot: 13.682.35
Beta prot: 10.221.24
Gamma prot: 14.445.11
25.3312.45 ALT: 44.215.67
AST
42.8918.12
N.R.
Alb: albumin; ALT: alanine transaminase; AST: aspartate transaminase; F: females; Hb: levels of Hemoglobin;M:males; N.R.: within the normal ranges; RBC: Red blood cells; VES: Erythrocyte sedimentation rate;WBC:White blood
cells.
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Table 2
immunological and serological blood parameters of patients enrolled in our study, stratiﬁed by groups of years.
Distribution
of patients
by range of
years
Serum IgA Serum IgM Serum IgG Complement Rickettsiae
Serum
diagnosis
OX19
Rickettsiae
Serum
diagnosis
OXK
Rickettsiae
Serum
diagnosis
OX2
Rickettsiae
Serum
diagnosis
OXQ
1987-1990 129.419.24 151.0223.04 113058.30 C3 72.7819.92
C4
48.329.80
1/80 (40%) 1/20 (40%)
1/80 (40%)
Negative (100%) Negative (100%)
1991-1994 71.195.54 160.715.86 72585.55 C3 82.210.10
C4
32.368.96
1/20 (10%)
1/40 (10%)
1/20 (10%)
1/40 (12.5%)
1/80 (20%)
1/320 (10%)
1/20 (20%)
1/40 (30%)
1/320 (10%)
1/20 (12.5%)
1/40 (12.5%)
1995-1998 78.617.34 151.627.68 1057.2593.52 C3 66.879.18
C4
35.624.03
1/40 (12.5%)
1/80 (12.5%)
1/40 (12.5%) 1/160 (12.5%)
1/320 (12.5%)
1/40 (12.5%)
1/640 (12.5%)
1999-2002 82.768.24 157.789.64 1102.5563.32 C3 72.777.18
C4
42.527.24
1/10 (14.25%)
1/20 (28.57%)
1/80 (14.25%)
1/40 (28.57%)
1/80 (14.25%)
1/640 (28.57)
1/20 (14.25%)
1/40 (14.25%)
1/80 (14.25%)
Negative (100%)
2003-2006 167.8132.12 187.3622.34 1184.9086.87 C3 121.3737.73
C4
60.1189.10
1/20 (18.18%)
1/80 (18.18%)
1/20 (27.27%)
1/40 (9.09%)
1/80 (9.09%)
1/160 (9.09%)
1/20 (9.09%)
1/160 (9.09%)
1/320 (9.09%)
1/20 (18.18%)
1/80 (18.18%)
2007-2010 79.426.22 174.1213.78 1028.4582.857 C3 65.5722.43
C4
46.118.30
1/20 (7.14%)
1/80 (21.42%)
1/20 (21.24%)
1/40 (21.24%)
1/80 (21.24%)
1/320 (7.14%)
1/20 (7.14%)
1/40 (21.24%)
1/80 (21.24%)
1/320 (7.14%)
1/20 (21.24%)
1/80 (7.14%)
G. Vitaliti et al. / International Journal of Infectious Diseases 31 (2015) 35–4038Studying the serological aspect of R. conorii antigens by Weil-
Felix and Vidal-Wright serodiagnosis, we noticed a different
representation of R. conorii antigens over time, corresponding to
higher incidence rates of infection in the latter years (Figure 1).Table 3
Clinical features and therapeutic follow-up of patients enrolled in our study, stratiﬁed
Distribution
of patients
by range
of years
Presence of
Tache noire
Skin rash site 
1987-1990 1%
(1 on 5 cases)
Generalized (40%)
Hands and inferior limbs (40%)
Trunk (20%)
1991-1994 10%
(1 on 10 cases)
Generalized (80%)
Trunk, hands and feet (20%)
1995-1998 12.5%
(1 on 8 cases)
Generalized (75%)
Trunk, hands and feet (12.5%)
Trunk, face, hands, feet (12.5%)
1999-2002 14.28%
(1 on 7 cases)
Generalised (57.14%)
Face and superior and inferior limbs (14,.8%)
Trunk (14.28%)
Hands and feet (14.28%)
2003-2006 36.36%
(4 on 11 cases)
Generalised (63.63%)
Limbs, Hands and feet (18.18%)
Trunk, hands and feet (17.57%)
2007-2010 57.14%
(8 on 14 cases)
Generalised (44.45%)
Face and superior and inferior limbs (15.23%)
Trunk (14.23%)
Hands and feet (46.73%)Whilst the most representative antigens from 1987 to 1990 were
OX19 and OXK, between 1991 and 1994 there was increased
expression of the OX2 antigen, and from 1995 to 2010 all four R.
conorii antigens, including OXQ, were highly expressed. The by groups of years.
Days of
hospital
admission
Symptoms
duration
(days)
Fever
duration
(days)
Therapy
3.60.89 5.261.34 2.81.48 Topical clortetracicline,
Ampicillin, Clavulanic acid,
Macrolide,
Anti-inﬂammatory therapy
7.11.67 5.10.87 52.30 Topical clortetracicline,
Macrolide,
Anti-inﬂammatory therapy
4.871.12 3.51.60 5.874.54 Topical clortetracicline,
Ampicillin, Clavulanic acid,
Macrolide,
Anti-inﬂammatory therapy
9.141.89 8.573.50 7.922.76 Topical clortetracicline,
Ceftazidime
Macrolide,
Anti-inﬂammatory therapy
5.181.99 5.53.17 5.222.92 Topical clortetracicline,
Clavulanic acid,
Cefpodoxima Proxetil,
Macrolide,
Anti-inﬂammatory therapy
3.921.20 7.122.49 4.151.18 Cloramphenicol,
Claritromicine
Macrolide,
Anti-inﬂammatory therapy
Figure 1. a: Distribution of R. conorii antigens, positive to the serum diagnosis of patients included in our study from 1987 to 1990
b: Distribution of R. conorii antigens, positive to the serum diagnosis of patients included in our study from 1991 to 1994
c: Distribution of R. conorii antigens, positive to the serum diagnosis of patients included in our study from 1995 to 1998
d: Distribution of R. conorii antigens, positive to the serum diagnosis of patients included in our study from 1999 to 2002
e: Distribution of R. conorii antigens, positive to the serum diagnosis of patients included in our study from 2003 to 2006
f: Distribution of R. conorii antigens, positive to the serum diagnosis of patients included in our study from 2007 to 2010
G. Vitaliti et al. / International Journal of Infectious Diseases 31 (2015) 35–40 39exception was the years 1999-2002, during which the OXQ antigen
was not represented (Figure 1). We also observed a higher
incidence of infection in those years in which all four antigens were
found positive at serodiagnosis with respect to those years in
which only two of the four antigens were represented (1987-1990:
0-16%; 2007-2010: 0.46%; P<0.005).
4. Discussion
This study found an increasing incidence of Rickettsia infection
causing MSF in children living in Catania, Sicily, Italy, from 1987 to
2010. This was associated with a concurrent change of antigenicity
of R. conorii, with a higher expression of pathogenic antigens. The
widespread incidence of pets living in domestic environments
seems to be linked to a higher incidence of R. conorii infections.8
Rickettsial microorganisms are symbiotic parasites of arthro-
pods, and their life cycle includes a ﬁrst phase in which these
parasites live inside arthropods, such as lice, ﬂeas, mites and ticks,
while in a second phase they reproduce inside warm-blooded
animals, including dogs, rats, ovine, bovines, and human beings.
For some types of Rickettsia, human beings represent a phase oftheir normal life cycle, whereas for the Rickettsia responsible for
exanthematous Typhus, for example, the human being represents
the only warm-blooded carrier.8 Thus close proximity of the
different hosts can facilitate transport and subsequent infection.
Rickettsiae are mostly intracellular parasites, with the excep-
tion of the Rickettsia responsible for the Quintana fever, which is
the unique extracellular microorganism.9 Their pathogenic action
is linked to cellular damage caused by the production of endotoxin
acting on the endothelial walls of arteriole and capillaries. This
endotoxin can cause inﬂammatory lesions, with consequent
production of nodules, perivascular lesions, sometimes associated
with vessel rupture or vessel occlusion, eventually evolving into
overt Disseminated Intravascular Coagulation (DIC).9
Among the different species of Rickettsiae, R. conorii is endemic
in the Mediterranean area and is the etiologic agent for the MSF
and the Mediterranean exanthematous fever (MEF). Nevertheless,
other Rickettsia species also may be present in the Mediterranean
area as a consequence of globalization and immigration, although
no current studies are available that have explored this.
Rhipicephalus sanguineus, the brown tick of dogs, represents the
most common vector of R. conorii. The epidemiological course of
G. Vitaliti et al. / International Journal of Infectious Diseases 31 (2015) 35–4040MSF is strictly linked to the biological features of this tick, and the
infection manifests itself in a seasonal pattern, with a higher
incidence between June and October.9 The common aspect in the
history of infected people is daily contact with their household
animals, especially dogs.
In our study we found a higher incidence of Rickettsia infection
in childhood from 1987 to 2010, also reﬂecting a greater
representation of the four R. conorii antigens, as analysed by
Weil-felix and Vidal-Wright serum diagnosis. These changes in R.
conorii antigenicity may be the cause for the higher pathogenicity
of this parasite and may be caused by the widespread phenomena
of immigration, with changes in the epidemiology of infectious
diseases in host countries. In this regard, the presence of new R.
conorii genotypes by multispacer typing of Rickettsia on skin
biopsies has recently been demonstrated. These genotypes have
been referred to subspecies groups of R. conorii, named R. conorii
subsp conorii and subsp israelensis.10
It is curious that only 16% of cases reported a tick puncture before
the onset of symptoms and only in 29.09% of cases was there
evidence of the presence of Tache Noire. This observation highlights
the non-speciﬁc presentation of Rickettsial infections and the
absence of typical signs associated with Rickettsia infection, making
the differential diagnosis with other infectious diseases more
complex. The common clinical signs in our included patients were
persistent fever and skin rash, predominantly centripetally distrib-
uted, and associated with various non-speciﬁc symptoms. In only
2 cases did we observe bilateral conjunctivitis, considering that
there have been rare reports of cases with conjunctival infection or
secondary ocular involvement of the infection from widespread,
itchy skin lesions.11 An interesting aspect of the studied patients,
from a clinical point of view, is the atypical presentation of the
diseases. Most patients were admitted in our Paediatric Acute and
Emergency Room for fever and skin rash, without any other
symptoms or signs of the disease. Therefore, differential diagnosis
with other exanthematous diseases was clinically difﬁcult. This is an
important aspect to note because this atypical presentation may be
the cause for the misdiagnosis of this disease, especially when
children are admitted in the Regional Paediatric Ambulatories and
are being treated with common antibiotics as a consequence of the
misdiagnosis of the real disease. The importance of the knowledge of
these atypical presentations requires more detailed data on the real
epidemiology of Rickettsioses.
All patients had normal routine blood parameters, including the
coagulation proﬁle, and no complications were observed because
antibiotic therapy was started soon after the results of serological
exams.
It is important to know the epidemiology of Rickettsioses to
establish the correct antibiotic therapy (mainly chlaritromicine in
paediatric patients) in order to prevent a possible evolution of the
disease toward its serious complications. Moreover, the right
antibiotic therapy also should be used in those cases in which there
is doubt regarding R. conorii infection, particularly if the patient’s
history is positive for any tick puncture or any contact with
household animals in the presence of persistent fever.A bias of our study is the low number of misdiagnoses of
infection, which is due to a lack of knowledge of the real
epidemiology and incidence of Rickettsioses, as they are incorrect-
ly considered rare infections and more often are treated in the
paediatric ambulatory unit without further routine controls,
risking the onset of complications and the spread of carriers.
Therefore we want to stress the importance of our study in
improving knowledge about this infectious disease, especially in
its atypical forms, aiding the paediatrician considering a diagnosis
of Rickettsia infection in cases presenting with fever and skin rash
but without its typical Tache Noire, and encouraging the scientiﬁc
population to diagnose those cases of Rickettsia infection to avoid
further spread of the disease. Moreover, a more detailed study
should involve the Regional Paediatric sites of access within the
Paediatric Ambulatories because most of these patients are not
then transferred to the referring Hospital but are usually treated by
the Paediatric Physicians with wide spectrum antibiotics, resulting
in a consequent underestimation of the problem. Therefore, this
study may represent the starting point leading to other larger
epidemiologic studies.
The aim of this retrospective study was to report a hygienic-
epidemiological analysis of MSF infection in childhood, to better
identify eventual carriers responsible for the spread of Rickettsia
infection, and to highlight the importance of prompt clinical and
therapeutic follow-up in order to encourage early diagnosis of
the disease, allowing less aggressive but more efﬁcient therapeutic
strategies.
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